000 01242 a2200349 4500
005 20250518095822.0
264 0 _c20200914
008 202009s 0 0 eng d
022 _a2297-3486
024 7 _a10.1159/000504485
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaupèze, Béatrice
245 0 0 _aNovel Technologies to Improve Vaccines for Older Adults.
_h[electronic resource]
260 _bInterdisciplinary topics in gerontology and geriatrics
_c2020
300 _a218-233 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdjuvants, Immunologic
_xstandards
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCommunicable Diseases
_ximmunology
650 0 4 _aHerpes Zoster
_xprevention & control
650 0 4 _aHerpes Zoster Vaccine
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunosenescence
_ximmunology
650 0 4 _aMiddle Aged
650 0 4 _aVaccination
650 0 4 _aVaccines
_xstandards
700 1 _avan der Most, Robbert
700 1 _aDel Giudice, Giuseppe
773 0 _tInterdisciplinary topics in gerontology and geriatrics
_gvol. 43
_gp. 218-233
856 4 0 _uhttps://doi.org/10.1159/000504485
_zAvailable from publisher's website
999 _c30872775
_d30872775